N-[1-[(3,5-dimethylisoxazol-4-yl)methyl]pyrazol-4-yl]-2-hydroxy-benzamide

ID: ALA4588973

PubChem CID: 155567505

Max Phase: Preclinical

Molecular Formula: C16H16N4O3

Molecular Weight: 312.33

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1noc(C)c1Cn1cc(NC(=O)c2ccccc2O)cn1

Standard InChI:  InChI=1S/C16H16N4O3/c1-10-14(11(2)23-19-10)9-20-8-12(7-17-20)18-16(22)13-5-3-4-6-15(13)21/h3-8,21H,9H2,1-2H3,(H,18,22)

Standard InChI Key:  NQKSTIPGOJEGMR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   22.6832  -19.2536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5004  -19.2536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7548  -18.4768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0918  -17.9947    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.4331  -18.4768    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.2020  -19.9141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5323  -18.2254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9800  -19.9152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7928  -19.8308    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.3380  -20.4386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0849  -20.1071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0004  -19.2943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2013  -19.1236    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.7922  -20.5166    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.5003  -20.1088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2076  -20.5182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5013  -19.2916    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.2018  -21.3347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9082  -21.7440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6173  -21.3362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6157  -20.5148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9087  -20.1092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4923  -21.7402    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  1  1  0
  1  6  1  0
  3  7  1  0
  2  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 16  1  0
 18 23  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4588973

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 312.33

Molecular Weight (Monoisotopic): 312.1222

AlogP: 2.49

#Rotatable Bonds: 4

Polar Surface Area: 93.18

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.93

CX Basic pKa: 1.71

CX LogP: 1.61

CX LogD: 1.50

Aromatic Rings: 3

Heavy Atoms: 23

QED Weighted: 0.77

Np Likeness Score: -2.32

References

1. Fotsing JR, Darmohusodo V, Patron AP, Ching BW, Brady T, Arellano M, Chen Q, Davis TJ, Liu H, Servant G, Zhang L, Williams M, Saganich M, Ditschun T, Tachdjian C, Karanewsky DS..  (2020)  Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists.,  63  (9): [PMID:32330040] [10.1021/acs.jmedchem.0c00388]

Source

Source(1):

• Scientific Literature